RNXT

RENOVORX INC

RNXT·75989R107·US·Common Stock·Healthcare - Biotechnology-13D/G

RNXT (RENOVORX INC) is held by 20 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.5M), GEODE CAPITAL MANAGEMENT, LLC ($385,561), Wealthspire Advisors, LLC ($255,051). Net institutional sentiment: Bullish.

20
Holders
(3 Elite)
$2.8M
Total Value
73% (15)
Consensus
11 buying - 4 selling
13F: Insider & Congress:
RNXT

Smart Money Verdict

View all
Held by 20 funds
3 elite

Who's Trading

InsiderVMVOLL MARKBuy $20KMay 19, 2026
ActivistOHOrin Hirschman9.8%Apr 27, 2026
InsiderBSBagai ShaunBuyMar 20, 2026
InsiderVMVOLL MARKBuyMar 20, 2026
InsiderMLMarton LaurenceBuyMar 20, 2026
InsiderARAgah RamtinBuy $10KJan 21, 2026
InsiderBSBagai ShaunBuy $5KDec 18, 2025
InsiderBSBagai ShaunBuy $4KDec 17, 2025
InsiderARAgah RamtinBuy $10KDec 16, 2025
ActivistAIAWM Investment Company, Inc.2.4%Nov 13, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
1.4M$1.5M0.0%+34.94%
39
Increased
381,723(+2.8%)$385,5610.0%-9.20%
17
Unchanged
252,525$255,0510.0%+27.27%
0
Increased
232,684(+335.7%)$235,0110.0%+23.04%
25
New
157,902$159,4810.0%+34.94%
34
Increased
99,460(+33.3%)$100,4550.0%-4.07%
28
Unchanged
42,161$42,5830.0%+5.10%
0
Unchanged
35,520$35,8750.0%+5.66%
0
Decreased
30,511(-39.1%)$30,8160.0%+4.75%
0
Unchanged
26,152$26,4140.0%-43.04%
0
Increased
24,137(+73.6%)$24,3780.0%+8.76%
20
Unchanged
20,000$20,2000.0%+12.00%
0
Increased
18,000(+63.6%)$18,1800.0%+30.14%
18
Decreased
13,000(-88.9%)$13,1300.0%-11.81%
0
Unchanged
12,307$12,4300.0%-12.50%
0
Unchanged
11,000$11,1100.0%+12.00%
0
Increased
7,102(+533.5%)$7,1730.0%+33.67%
18
Increased
3,917(+3916x)$3,9560.0%+34.92%
16
Increased
3,338(+46.5%)$3,3710.0%+24.35%
13
Increased
43,120(+302.0%)$430.0%+19.43%
18

Showing 1-20 of 22

1 / 2
RNXTRNXTRENOVORX INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used